de RosasECWangJCZiglerCK, et al. Methotrexate and mycophenolate mofetil and clinical response in juvenile localized scleroderma. JAMA Dermatol. 2026;162(3):271-278. doi:10.1001/jamadermatol.2025.5662
2.
HamaguchiYUeda-HayakawaIKanekoU, et al. Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan. J Dermatol. 2025;52(5):860-871. doi:10.1111/1346-8138.17684
3.
Christen-ZaechSHakimMDAfsarFSPallerAS.Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59(3):385-396. doi:10.1016/j.jaad.2008.05.005
4.
BarnawiGBobicaACBinJadeedHGhazalSNetchiporoukE.Phosphodiesterase-4 inhibition in localized scleroderma: a case series of topical roflumilast. SAGE Open Med Case Rep. 2025;13:Article 2050313X251406440. doi:10.1177/2050313X251406440
5.
SinkJChiuYE.Pediatric morphea state-of-the-art literature review: reframing morphea as a systemic disease. Pediatr Dermatol. 2021;38(5):1020-1031. doi:10.1111/pde.14620
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
